APA (7th ed.) Citation

Ahmed Sabt, Wagdy M. Eldehna, Tarfah Al-Warhi, Ohoud J. Alotaibi, Mahmoud M. Elaasser, Howayda Suliman, & Hatem A. Abdel-Aziz. (2020). Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: Synthesis, biological evaluation and in silico insights. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ahmed Sabt, Wagdy M. Eldehna, Tarfah Al-Warhi, Ohoud J. Alotaibi, Mahmoud M. Elaasser, Howayda Suliman, and Hatem A. Abdel-Aziz. Discovery of 3,6-disubstituted Pyridazines as a Novel Class of Anticancer Agents Targeting Cyclin-dependent Kinase 2: Synthesis, Biological Evaluation and in Silico Insights. Taylor & Francis Group, 2020.

MLA (9th ed.) Citation

Ahmed Sabt, et al. Discovery of 3,6-disubstituted Pyridazines as a Novel Class of Anticancer Agents Targeting Cyclin-dependent Kinase 2: Synthesis, Biological Evaluation and in Silico Insights. Taylor & Francis Group, 2020.